Page 1 of 4
1234

Garabrant DH, Alexander DD, Miller PE, Fryzek JP, Boffetta P, Teta MJ, Hessel PA, Craven VA, Kelsh MA, Goodman M. 2016. Response to Kay Teschke. Re: Mesothelioma among motor vehicle mechanics: An updated review and meta-analysis. Ann Occup Hyg 60(8):1036-1037.

View Abstract

Beebe-Dimmer JL, Fryzek JP, Yee CL, Dalvi T, Garabrant DH, Schwartz AG, Gadgeel S. 2016. Mesothelioma in the United States: A Surveillance, Epidemiology and End Results (SEER)-Medicare investigation of treatment patterns and overall survival. Clin Epidemiol 8:743-750.

Cukor D, Cohen LM, Cope EL, Ghahramani N, Hedayati SS, Hynes DM, Shah VO, Tentori F, Unruh M, Bobelu J, Cohen SS, Dember LM, Faber T, Fischer MJ, Gallardo R, Germain MJ, Ghahate D, Grote N, Hartwell L, Heagerty P, Kimmel PL, Kutner N, Lawson S, Marr L, Nelson RG, Porter AC, Sandy P, Struminger BB, Subramanian L, Weisbord S, Young B, Mehrotra R. 2016. Patient and other stakeholder engagement in patient-centered outcomes research institute funded studies of patients with kidney diseases. Clin J Am Soc Nephrol 11(9):1703-1712.

View Abstract

Cronin-Fenton D, Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Mortensen K, Midta A, Shire N, Brody R, Fryzek J, Lawrence D, Rigas J, Potter D, Walker J, Mellemgaard A, Rasmussen TR, Hamilton-Dutoit S, Sorensen HT. An interim assessment of key biomarkers (programmed cell death receptor ligand 1 (PD-L1) expression and epidermal growth factor receptor (EGFR) in third-line therapy non-small cell lung cancer (NSCLC) patients: A Danish cohort study. Presented at the 41st European Society for Medical Oncology (ESMO) Congress, October 7-11 2016, Copenhagen, Denmark.

Chamberlain AM, Cohen SS, Killian JM, Beaubrun AC, Monda KL, Hedgeman E, Weston SA, Okerson T. Lipid-Lowering Therapy Prescriptions Immediately Before and After the Diagnosis of Diabetes or Atherosclerotic Cardiovascular Disease. Presented at the American Heart Association Scientific Sessions, November 1, 2016, New Orleans, LA.

Alexander DD, Yan J, Bylsma LC, Northington RS, Grathwohl D, Steenhout P, Erdmann P, Spivey-Krobath E, Haschke F. 2016. Growth of infants consuming whey-predominant term infant formulas with a protein content of 1.8 g/100 kcal: A multicenter pooled analysis of individual participant data. Am J Clin Nutr 104(4):1083-1092.

View Abstract

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of Respiratory Syncytial Virus Disease among Adults in the United States from 1997 to 2012. Presented at ID Week 2016, October 26-30, 2016, New Orleans, LA.

Cronin-Fenton D , Dalvi T, Hedgeman E, Norgaard M, Pedersen L, Mortensen K, Midta A, Shire N, Brody R, Fryzek J, Lawrence D, Rigas J, Potter D, Walker J, Mellemgaard A, Rasmussen TR, Hamilton-Dutoit S, Sorensen HT. An interim assessment of key biomarkers (programmed cell death receptor ligand 1 (PD-L1) expression and epidermal growth factor receptor (EGFR) in third-line therapy non-small cell lung cancer (NSCLC) patients: A Danish cohort study. Presented at the 41st European Society for Medical Oncology (ESMO) Congress, October 7-11 2016, Copenhagen, Denmark.

Pastula S, Hackett J, Coalson J, Jiang X, Villafana T, Fryzek J. Burden of respiratory syncytial virus disease among adults in the United States from 1997 to 2012. Presented at the International Society for Influenza and Other Respiratory Virus Diseases (ISIRV) 2016 – Options IX For the Control of Influenza, August 24-28, 2016, Chicago, IL.

Cetin K, Callaghan F, Fryzek J, Bylsma L, Bezold C, Mehta B. Safety and Efficacy/Effectiveness of 2nd-line Treatments in Immune Thrombocytopenia (ITP): A Systematic Review of the Literature. Presented at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 25-28, 2016, Dublin, Ireland.

Page 1 of 4
1234